Medical inflation rises to 11.3%: How Asia-Pacific cost pressures affect Oceania employers and regional healthcare systems

Asia Pacific Medical Inflation: Structural Challenges Facing Oceania

According to Aon's *Global Medical Trend Rate Report*, the medical inflation rate in the Asia Pacific region is projected to reach 11.3% in 2026, marking the second consecutive year above the global average (9.8%). Despite signs of easing in some markets, employers and healthcare systems in Oceania are facing unique cost pressures—a trend that not only tests corporate benefit budgets but also reflects deep-seated contradictions in regional medical resource allocation, population structure, and insurance markets.

Background: Why Are Medical Costs in Asia Pacific So High?

The report points out that Asia Pacific is the only region where medical inflation has risen year-on-year (+20 basis points), even as general inflation has declined. The gap between medical inflation and general inflation has widened to 8.9 percentage points, indicating structural drivers: aging populations, increasing chronic disease burdens, rising utilization of private medical care, costs of imported medical technology and pharmaceuticals, and lifestyle-related diseases.

These factors are particularly pronounced in Oceania. Australia's population aged 65 and over already exceeds 16%, while New Zealand is close to 15%. Although Pacific island nations have relatively younger populations, they have the highest rates of non-communicable diseases (such as diabetes and cardiovascular disease) globally, with medical resources heavily dependent on imports and international aid.

Impact on Employers in Oceania: Cost Squeeze and Benefit Restructuring

The report shows that 70% of global multinationals have listed cost control as their top benefits goal, and in the Asia Pacific region, employers are increasingly relying on data analytics and negotiation strategies. Employers in Australia and New Zealand face dual pressures: on one hand, medical inflation drives up insurance premiums; on the other hand, rising employee expectations for high-quality healthcare force companies to adjust benefit designs.

Australia: Private Hospital System Under Pressure

Australia has a mixed healthcare system, with about half the population purchasing private health insurance. As medical inflation exceeds 10%, insurers are forced to raise premiums, with average increases already exceeding 6% in 2024. A case study in Aon's report shows that introducing co-payments can reduce per-capita claims costs by 10%, but employers must carefully manage employee feedback—63% of surveyed companies consider employee opinion a major barrier to implementing cost containment.

New Zealand: Public System Spillover Boosts Demand for Private Insurance

Longer waiting times in New Zealand's public healthcare system are driving more businesses and individuals toward private insurance. The report notes that chronic diseases and the cost of imported medical technology are key drivers. New Zealand employers are reducing long-term risks through health promotion programs (wellbeing programs); for example, one case shows such programs reduced health claims by 11.2%.

Pacific Island Nations: High Vulnerability and External DependenceFor island nations such as Fiji, Papua New Guinea, and Samoa, the impact of medical inflation is more severe. These countries have weak healthcare systems, with almost all medicines and equipment relying on imports, and exchange rate fluctuations directly drive up costs. The Aon report mentioned that some markets in Southeast Asia have seen moderation in inflation due to the promotion of health plans, but Pacific island nations, lacking economies of scale and local production capacity, cannot replicate such achievements in the short term. Employers (mostly governments and international organizations) face budget constraints, and the coverage rate of employee benefits may decline.

Regional Impact: How Rising Healthcare Costs Are Reshaping Oceania's Economy?

Medical inflation has gone beyond the scope of corporate benefits and has a profound impact on Oceania's macroeconomy:

• Rising labor costs: To maintain benefit competitiveness, companies need to allocate more budget to medical insurance, squeezing space for other investments and salary growth.
• Insurance market reshaping: Insurers face claims pressure and may increase deductibles or narrow coverage. Australia's health insurance industry is undergoing consolidation and product innovation, while New Zealand is seeing more insurance plans combined with health promotion.
• Public fiscal pressure: Governments need to increase funding for public hospitals or subsidize private insurance. Medical spending in the Australian federal budget grows by about 5% annually, and medical inflation exacerbates this trend.
• Regional investment flows: Medical infrastructure has become an emerging investment area. Australia is advancing digital health technologies (e.g., telemedicine), New Zealand is increasing investment in chronic disease prevention, while Pacific island nations rely on health project financing from institutions such as the Asian Development Bank and the World Bank.

Trade and Supply Chain Perspective: Cost Transmission of Imported Medical Technology

About 30% of medical inflation is attributed to imported medical technologies and pharmaceuticals. Oceania, as a net importer of medical products, is affected by global supply chain fluctuations and currency depreciation. Changes in the Australian dollar and New Zealand dollar exchange rates against the US dollar directly affect hospital procurement costs. Some Pacific island nations use the US dollar as their settlement currency, experiencing greater price volatility. The report notes that currency exposure in the Asia-Pacific region is an important factor driving medical inflation.

Long-term Trends: Oceania's Medical Outlook for the Next 3-5 Years

Looking ahead to 2026-2030, medical inflation in Oceania may show divergence:

• Australia and New Zealand: With the increase in digital healthcare and preventive investments, medical inflation may gradually stabilize between 8% and 10%. However, population aging will continue to push up chronic disease treatment costs, and private insurance penetration may further increase.
• Pacific island nations: Medical inflation may remain above 12% unless more development assistance or localized pharmaceutical production is obtained. Climate-related diseases (e.g., dengue fever, tropical diseases) will add additional demand.
• Regional cooperation: The Pacific Islands Forum (PIF) is promoting a regional medical supplies procurement mechanism to reduce import costs. Medical cooperation projects with Australia and New Zealand (such as the Pacific Health Workforce Program) are expected to alleviate some pressure.

Conclusion## Conclusion

Medical inflation, persistently higher than general inflation, has become a systemic risk for Oceania economies. Employers need to find a balance between cost control and employee satisfaction, while governments must rethink public healthcare financing models. Over the next five years, the competitiveness of medical costs will be a key variable affecting the regional investment environment. For Australia and New Zealand, insurance innovation and digital healthcare are the key breakthroughs; for Pacific island nations, external aid and regional integration are the only sustainable paths. Healthcare is no longer just a welfare issue, but a core economic topic running through labor markets, public finances, and regional development.

---

*Sources: Aon Global Medical Trend Rates Report 2024, Asian Business Review, November 2024.*